Verona Pharma Ownership | Who Owns Verona Pharma?
Verona Pharma Ownership Summary
Verona Pharma is owned by 11.17% institutional investors, 10.63% insiders, and 78.20% retail investors. Morgan stanley is the largest institutional shareholder, holding 1.07% of VRNA shares. BlackRock Event Driven Equity Instl is the top mutual fund, with 2.33% of its assets in Verona Pharma shares.
VRNA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Verona Pharma | 11.17% | 10.63% | 78.20% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Morgan stanley | 864.03K | 1.07% | $12.49M |
| Perceptive advisors | 5.51M | 0.81% | $520.91M |
| Bank of america corp /de/ | 611.02K | 0.76% | $8.84M |
| Darwin global management | 3.92M | 0.58% | $245.98M |
| Blackrock | 430.43K | 0.53% | $6.22M |
| Frazier life sciences management | 3.38M | 0.50% | $320.05M |
| Wellington management group llp | 3.03M | 0.46% | $140.49M |
| Rtw investments, lp | 3.05M | 0.45% | $288.65M |
| Eventide asset management | 2.72M | 0.40% | $256.80M |
| Nea management company | 2.26M | 0.33% | $214.05M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Perceptive advisors | 5.51M | 19.31% | $520.91M |
| Caligan partners lp | 1.44M | 19.04% | $91.23M |
| Darwin global management | 3.92M | 16.81% | $245.98M |
| Aisling capital management lp | 615.35K | 16.18% | $58.20M |
| Nea management company | 2.26M | 16.11% | $214.05M |
| Vivo capital | 1.39M | 13.49% | $131.79M |
| Frazier life sciences management | 3.38M | 12.80% | $320.05M |
| Ally bridge group (ny) | 160.70K | 12.65% | $15.20M |
| Artia global partners lp | 538.49K | 8.65% | $34.19M |
| Tyro capital management | 214.72K | 7.97% | $20.31M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Darwin global management | 3.92M | 16.81% | 3.11M |
| Wellington management group llp | 3.03M | 0.03% | 1.15M |
| Polar capital | 875.00K | 0.43% | 875.00K |
| Farallon capital management | 1.81M | 0.74% | 725.01K |
| Janus henderson group | 1.67M | 0.04% | 624.37K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Orbimed advisors | - | - | -2.86M |
| Carlyle group | - | - | -2.46M |
| Ra capital management | - | - | -1.77M |
| Maverick capital | 521.86K | 0.74% | -1.26M |
| Perceptive advisors | 5.51M | 19.31% | -1.06M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Polar capital | 875.00K | 0.43% | 875.00K | $82.76M |
| Westfield capital management co lp | 539.81K | 0.21% | 539.81K | $51.06M |
| Castle hook partners lp | 372.80K | 0.20% | 372.80K | $35.26M |
| Cormorant asset management, lp | 350.00K | 2.47% | 350.00K | $33.10M |
| Driehaus capital management | 338.36K | 0.26% | 338.36K | $32.00M |
Sold Out
| Holder | Change |
|---|---|
| Zurcher kantonalbank (zurich cantonalbank) | -2.00 |
| Hexagon capital partners | -3.00 |
| Td private client wealth | -30.00 |
| Coldstream capital management | -67.00 |
| Naples money management | -100.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 311 | 10.68% | 75,907,698 | 5.10% | 11 | 9.89% | 149 | -7.45% | 111 | 32.14% |
| Mar 31, 2025 | 25 | -88.37% | 22,667,271 | -66.98% | 3 | 3.01% | 15 | -86.96% | 5 | -92.06% |
| Dec 31, 2024 | 201 | 23.31% | 61,094,145 | -9.72% | 9 | 0.14% | 106 | 23.26% | 61 | 22.00% |
| Sep 30, 2024 | 161 | 21.97% | 67,432,127 | 2.42% | 82 | 1.25% | 85 | 19.72% | 49 | 48.48% |
| Jun 30, 2024 | 131 | 11.97% | 65,836,577 | -1.14% | 81 | 1.16% | 70 | 18.64% | 33 | 22.22% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| BlackRock Event Driven Equity Instl | 2.01M | 2.33% | 2.01M |
| Eventide Gilead N | 1.89M | 2.22% | - |
| T. Rowe Price Health Sciences | 1.36M | 1.60% | -8.06K |
| Bellevue Healthcare Ord | 1.10M | 1.36% | 1.10M |
| Eventide Healthcare & Life Sciences I | 988.17K | 1.16% | -241.83K |
| Janus Henderson Global Life Sciences | 928.45K | 1.09% | 166.86K |
| Janus Henderson Global Life Sciences D | 928.45K | 1.08% | -93.09K |
| Polar Capital Biotech S Inc | 875.00K | 1.03% | - |
| Hood River Small-Cap Growth Instl | 820.64K | 0.95% | -18.27K |
| Janus Henderson Glb Life Scn I2 USD | 769.69K | 0.90% | -58.88K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 01, 2025 | Cunningham Kenneth | - | Sell | $142.06K |
| Aug 01, 2025 | Deschamps Lisa | - | Sell | $124.39K |
| Aug 01, 2025 | Fisher Andrew | General Counsel | Sell | $125.97K |
| Aug 01, 2025 | Hahn Mark W | Chief Financial Officer | Sell | $2.75M |
| Aug 01, 2025 | Rickard Kathleen A. | Chief Medical Officer | Sell | $766.75K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | - |
| 2025 Q2 | - | 26 |
| 2025 Q1 | - | 1 |
| 2024 Q4 | 3 | 33 |
| 2024 Q3 | 1 | 8 |
VRNA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools